Viral intervention of ICAM5 expression in DG reverses the cognitive deficits in the FXS mouse model Fmr1 KO mice, demonstrating the therapeutic value of ICAM5 for treating cognitive dysfunctions in FXS. Here, FMR1 is linked to fragile X syndrome.